Ranolazine 59651-0009-99
- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 23, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209081
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
59651-0009-99Selected1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-99)
Other packages for this product(2)
180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-18)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-60)